ClearanceBrief
Recall Z-0779-2017 ยท CGJ Radioimmunoassay, Follicle-Stimulating Hormone

PerkinElmer Health Sciences, Inc.

DELFIA hFSH kit. In Vitro Diagnostic for the determination of hFSH in serum

DateDec 16, 2016 (initiated Nov 16, 2016)
StatusTerminated
ReasonA DELFIA hFSH kit lot failed real time stability testing. The real time stability data demonstrated a decrease in hFSH concentrations between -4.8% to -11.3% for control sera. The -11.3% bias was observed at an hFSH target concentration of 101 IU/L. The change observed in the serum samples within the range 1.76 67.0 IU/L hFSH averaged -2.9%. The reference range of the assay spans 0.60 to 98.0 IU/L.
Root causeOther
ActionPerkinElmer initiated recall on November 16, 2016, delivered to the end customer by email facilitated through the PerkinElmer Technical Support group located in Akron Ohio. Technical Support will be asked to make sure the customers receive the Recall Letter and understand the recommended actions. Users asked to inspect inventory, discontinue use destroy the kits and complete the Response Forms and Destruction.Replacement kits will shipped.
Quantity79 kits
DistributionCA, CO, NY, WA Foreign: Austria, Bolivia, Bosnia , Sweden, Norway, Netherlands, Japan, Great Britain,
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K862043DELFIA (TM) HFSH KIT
Lkb Instruments, Inc., Jun 24, 1986